Federico Felizzi
Basel, BS 4056, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
A Framework for the Estimation of Quality-Adjusted Life-Years Using Joint Models of Longitudinal and Survival Data.
Journal: Medical decision making : an international journal of the Society for Medical Decision Making
Published: August 31, 2026
Efficacy and Safety of Brolucizumab, Aflibercept, and Ranibizumab for the Treatment of Patients with Visual Impairment Due to Diabetic Macular Oedema: A Systematic Review and Network Meta-Analysis.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: March 24, 2023
Qualitative Exploration of the Visual Function Impairments and Health-Related Quality of Life Impacts of Amblyopia in Adult and Pediatric Populations.
Journal: Ophthalmology and therapy
Published: January 24, 2023
The Amblyopia Quality of Life (AmbQoL): Development and Content Validation of a Novel Health-Related Quality of Life Instrument for Use in Adult and Pediatric Amblyopia Populations.
Journal: Ophthalmology and therapy
Published: December 06, 2022
Correction to: Approximation of Long-Term Survival with Polatuzumab Vedotin Plus Bendamustine and Rituximab for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Results Based on The GO29365 Trial.
Journal: PharmacoEconomics - open
Published: September 12, 2022
A Social Media Listening Study to Understand the Unmet Needs and Quality of Life in Adult and Pediatric Amblyopia Patients.
Journal: Ophthalmology and therapy
Published: June 21, 2022
Approximation of Long-Term Survival with Polatuzumab Vedotin Plus Bendamustine and Rituximab for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Results Based on The GO29365 Trial.
Journal: PharmacoEconomics - open
Published: May 18, 2022
Machine Learning Methods in Health Economics and Outcomes Research-The PALISADE Checklist: A Good Practices Report of an ISPOR Task Force.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: March 22, 2022
Cost-effectiveness of obinutuzumab versus rituximab biosimilars for previously untreated follicular lymphoma.
Journal: Journal of managed care & specialty pharmacy
Published: February 15, 2021
Mixture Cure Models in Oncology: A Tutorial and Practical Guidance.
Journal: PharmacoEconomics - open
Published: February 07, 2021
US cost-effectiveness of polatuzumab vedotin, bendamustine and rituximab in diffuse large B-cell lymphoma.
Journal: Journal of comparative effectiveness research
Published: October 08, 2020
Cost-effectiveness of atezolizumab versus docetaxel and nivolumab in the treatment of non-small cell lung cancer as a second line in France.
Journal: Journal of medical economics
Published: January 18, 2020
Last Updated: 09/26/2026